Résultats de la recherche

search

Rechercher les filtres

Mot-clé
webcast
MBRX_Logo.png
Moleculin to Report Full Year 2024 Financial Results on March 21, 2025 and Host Conference Call and Webcast
19 mars 2025 08h05 HE | Moleculin Biotech, Inc.
HOUSTON, March 19, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates...
Logo_Pharming_original.png
Pharming Group reports fourth quarter and full year 2024 financial results and provides business update
13 mars 2025 02h00 HE | Pharming Group N.V.
Full year 2024 total revenues increased by 21% to US$297.2 million and exceeded our guidance, driven by record RUCONEST® revenue and strong Joenja® (leniolisib) growth Fourth quarter 2024 total...
Optinose_logo_RGB.png
Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results
11 mars 2025 16h15 HE | Optinose, Inc.
YARDLEY, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
MacroGenics-Logo-(transparent-background).png
MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call
06 mars 2025 07h30 HE | MacroGenics, Inc.
ROCKVILLE, MD, March 06, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal...
BWEN Logo.png
Broadwind Announces Fourth Quarter and Full-Year 2024 Results
05 mars 2025 07h00 HE | Broadwind, Inc.
CICERO, Ill., March 05, 2025 (GLOBE NEWSWIRE) -- Broadwind (Nasdaq: BWEN, or the “Company”), a diversified precision manufacturer of specialized components and solutions serving global markets,...
BeautyHealth_InLine.png
BeautyHealth to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025
04 mars 2025 16h05 HE | The Beauty Health Company
The Beauty Health Company will report fourth quarter and full year 2024 financial results after market close on Wednesday, March 12, 2025.
Logo_Pharming_original.png
Pharming Group to report fourth quarter and full year 2024 financial results on March 13
27 févr. 2025 02h00 HE | Pharming Group N.V.
Leiden, the Netherlands, February 27, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) fourth quarter and full year...
MYR Group logo
MYR Group Inc. Announces Fourth Quarter and Full Year 2024 Results
26 févr. 2025 16h07 HE | MYR Group, Inc.
THORNTON, Colo., Feb. 26, 2025 (GLOBE NEWSWIRE) -- MYR Group Inc. (“MYR” or the "Company") (NASDAQ: MYRG), a holding company of leading specialty contractors serving the electric utility...
Hillman_logo.jpg
Hillman to Present at the Raymond James 46th Annual Institutional Investors Conference
26 févr. 2025 07h30 HE | The Hillman Group
CINCINNATI, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Hillman Solutions Corp. (Nasdaq: HLMN) (the “Company” or “Hillman”), a leading provider of hardware products and merchandising solutions, announced its...
micron-logo-black (1).png
Micron Technology to Report Fiscal Second Quarter Results on March 20, 2025
20 févr. 2025 16h01 HE | Micron Technology, Inc.
BOISE, Idaho, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) announced today that it will hold its fiscal second quarter earnings conference call on Thursday, Mar. 20, 2025,...